Impact of adherence on response to therapy during treatment for acute and early chronic HCV infection
- Jason Grebely, National Centre in HIV Epidemiology and Clinical Research, University of New South Wales
|
Regarding the inclusion of testing and treatment services for Hepatitis C within existing pharmacotherapy clinics and considering the pros and cons of such a service
- Tess C Robinson, New South Wales Users and AIDs Association (N.U.A.A.)
- Ms Susan McGuckin, New South Wales Users and AIDs Association (N.U.A.A.)
|
Hepatitis C Treatment in Pharmacotherapy Services: Increasing Treatment Uptake Needs a Critical View
- A/Prof Carla Treloar, National Centre in HIV Social Research
|
Delivery of hepatitis C assessment and treatment for injecting drug users during rehabilitation initiated by primary care services
- Ms Ann White, Drug Health Services, Sydney South West Area Health Service
|
Hepatitis C treatment needs among opioid substitution treatment clients in inner-city Sydney
- Dr Carolyn A Day, Central Clinical School and Discipline of Addiction Medicine, University of Sydney, NSW
|